Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


09th week of 2012 patent applcation highlights part 56
Patent application numberTitlePublished
20120053124BINDER FOR C-REACTIVE PROTEIN2012-03-01
20120053125PHOSPHATASE INHIBITOR PROTEIN-1 AS A REGULATOR OF CARDIAC FUNCTION2012-03-01
20120053126Injection Paradigm for Administration of Botulinum Toxins2012-03-01
20120053127TARGETED DELIVERY OF BOTULINUM TOXIN TO THE SPHENOPALATINE GANGLION2012-03-01
20120053128Method of inhibiting angiogenesis2012-03-01
20120053129TARGET-ACTIVATED CELL/TISSUE-PENETRATING PEPTIDE FOR DELIVERY OF IMPERMEABLE COMPOUNDS AND USE THEREOF2012-03-01
20120053130COMPOSITION FOR ENHANCING ABSORPTION OF A DRUG AND METHOD2012-03-01
20120053131METHODS OF PREDICTING MEDICALLY REFRACTIVE ULCERATIVE COLITIS (MR-UC) REQUIRING COLECTOMY2012-03-01
20120053132COMPOSITIONS AND METHODS FOR INHIBITING CYTOCHROME P4502012-03-01
20120053133ANTISEPTIC AGENT COMPOSITION2012-03-01
20120053134PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING NEURONAL DAMAGE AND NEUROLOGICAL DISEASES2012-03-01
20120053135Drug composition for treating chronic liver disease and its application2012-03-01
20120053136DIAGNOSIS AND TREATMENT OF DRUG-RESISTANT EWING`S SARCOMA2012-03-01
20120053137Method for Treating Addiction Using Quercetin-Containing Compositions2012-03-01
20120053138FORMULATION OF A MIXTURE OF FREE-B-RING FLAVONOIDS AND FLAVANS FOR USE IN THE PREVENTION AND TREATMENT OF COGNITIVE DECLINE AND AGE-RELATED MEMORY IMPAIRMENTS2012-03-01
20120053139METHOD FOR IMPROVING PHARMACOKINETICS OF PROTEASE INHIBITORS AND PROTEASE INHIBITOR PRECURSORS2012-03-01
20120053140ADMINISTRATION OF AVERMECTIN/MILBEMYCIN COMPOUNDS FOR THE TREATMENT OF OPHTHALMIC PATHOLOGIES2012-03-01
20120053141Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis2012-03-01
20120053142COMPOSITIONS AND METHODS FOR MINIMIZING AND/OR REDUCING THE APPEARANCE OF DEFECTS AROUND EYES2012-03-01
20120053143TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT2012-03-01
20120053144Cobalamin Taxane Bioconjugates For Treating Eye Disease2012-03-01
20120053145ARIPIPRAZOLE COMPLEX FORMULATION AND METHOD2012-03-01
20120053146PESTICIDAL COMPOSITIONS2012-03-01
20120053147THIAZOLOPYRIMIDINONE DERIVATIVES AS PI3 KINASE INHIBITORS2012-03-01
20120053148INHIBITORS OF HEPATITIS C VIRUS2012-03-01
20120053149THIAZOLE DERIVATIVES AND THEIR USE AS P2Y12 RECEPTOR ANTAGONISTS2012-03-01
20120053150N-PYRAZOLYL CARBOXAMIDES AS CRAC CHANNEL INIHIBITORS2012-03-01
20120053151DIMETHOATE LOW VOC FORMULATIONS2012-03-01
20120053152(R)-(-)-1,2-propanediol compositions and methods2012-03-01
20120053153TOPICAL GEL FORMULATION COMPRISING ORGANOPHOSPHATE INSECTICIDE AND PREPARATION THEREOF2012-03-01
20120053154COMPOSITION AND METHOD FOR INHIBITING BIOGENIC SULFIDE GENERATION2012-03-01
20120053155SYSTEM AND METHOD FOR REVERTING ANTIBIOTIC TOLERANCE OF BACTERIAL PERSISTER CELLS2012-03-01
20120053156COMPOSITIONS AND METHODS FOR LOOP DIURETICS WITH CONSISTENT BIOAVAILABILITY2012-03-01
20120053157METHODS FOR THE TREATMENT OR PROPHYLAXIS OF THROMBOSIS OR EMBOLISM2012-03-01
20120053158PREPARATION OF AN ACETYL SALICYLIC ACID/GLUTAMIC ACID COMPLEX FOR ORAL ADMINISTRATION2012-03-01
20120053159ISOTOPOLOGUES OF LENALIDOMIDE2012-03-01
20120053160Dosage Form for Hormonal Contraception2012-03-01
20120053161TOPICAL SOLUTION FORMULATIONS CONTAINING A CORTICOSTEROID AND A CYCLODEXTRIN2012-03-01
20120053162CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS2012-03-01
20120053163Steroids as Agonists for FXR2012-03-01
20120053164CYCLIC PYRIMIDIN-4-CARBOXAMIDES AS CCR2 RECEPTOR ANTAGONISTS FOR TREATMENT OF INFLAMMATION, ASTHMA AND COPD2012-03-01
20120053165Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators2012-03-01
201200531664-Oxadiazol-2-YL-Indazoles as Inhibitors of P13 Kinases2012-03-01
20120053167Triazine Derivatives as Kinase Inhibitors2012-03-01
20120053168FUSED BENZOAZEPINES AS NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS2012-03-01
20120053169COMBINATION OF MORPHINAN COMPOUNDS AND ANTIDEPRESSANT FOR THE TREATMENT OF PSEUDOBULBAR AFFECT, NEUROLOGICAL DISEASES, INTRACTABLE AND CHRONIC PAIN AND BRAIN INJURY2012-03-01
20120053170NICOTINAMIDE DERIVATIVES, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF AS ANTICANCER DRUGS2012-03-01
20120053171Nitrogen-Containing Fused Heterocyclic Compounds and Their use as Beta Amyloid Production Inhibitors2012-03-01
20120053172USE OF A COMBINATION OF DIAZOXIDE AND METFORMIN FOR TREATING OBESITY OR OBESITY RELATED DISORDERS2012-03-01
20120053173HETEROCYCLIC COMPOUND2012-03-01
20120053174QUINAZOLINE COMPOUNDS AND METHODS OF USE THEREOF2012-03-01
20120053175MLK INHIBITORS AND METHODS OF USE2012-03-01
20120053176ADENOSINE A3 RECEPTOR MODULATING COMPOUNDS AND METHODS OF USE THEREOF2012-03-01
20120053177COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR2012-03-01
201200531783-(1,2,3-Triazol-4-yl) pyrrolo [2,3-b] pyridine derivatives2012-03-01
20120053179Rho-Kinase Inhibitors2012-03-01
20120053180CYCLOHEXANE ANALOGUES AS GPR119 AGONISTS2012-03-01
20120053181PYRROLIDINE-DERIVED BETA 3 ADRENERGIC RECEPTOR AGONISTS2012-03-01
20120053182METHODS OF ALLEVIATING OR TREATING SIGNS AND/OR SYMPTOMS ASSOCIATED WITH MODERATE TO SEVERE PARKINSON'S DISEASE2012-03-01
20120053183PIPERAZINYLPYRIMIDINE ANALOGUES AS PROTEIN KINASE INHIBITORS2012-03-01
20120053184SALTS OF 3-(1H-IND0L-3-YL)-4-[2-(4-METHYL-PIPERAZIN-I-YL)-QUINAZOLIN-4-YL]- -PYRROLE-2, 5-DI ONE2012-03-01
20120053185METHOD TO TREAT MELANOMA IN BRAF INHIBITOR-RESISTANT SUBJECTS2012-03-01
201200531862-(3-AMINOARYL) AMINO-4-ARYL-THIAZOLES AND THEIR USE AS C-KIT INHIBITORS2012-03-01
20120053187TRI-CYCLIC PYRAZOLOPYRIDINE KINASE INHIBITORS2012-03-01
20120053188COMPOUNDS, PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE OF HYDROXAMIC ACID DERIVATIVES2012-03-01
20120053189BTK INHIBITORS FOR THE TREATMENT OF IMMUNE MEDIATED CONDITIONS2012-03-01
20120053190ORGANIC COMPOUNDS2012-03-01
20120053191OXIDATED DERIVATIVES OF TRIAZOLYLPURINES USEFUL AS LIGANDS OF THE ADENOSINE A2A RECEPTOR AND THEIR USE AS MEDICAMENTS2012-03-01
20120053192Heterocyclic Substituted Acardite Derivate and Application Thereof2012-03-01
20120053193OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF2012-03-01
20120053194OPTICALLY ACTIVE PYRAZOLYLAMINOQUINAZOLINE, AND PHARMACEUTICAL COMPOSITIONS AND METHODS OF USE THEREOF2012-03-01
20120053195HYDROBROMIDE SALTS OF A PYRAZOLYLAMINOQUINAZOLINE2012-03-01
20120053196Combination Treatment of Breast Cancer2012-03-01
20120053197TRICYCLIC PYRIDINE DERIVATIVES, MEDICAMENTS CONTAINING SUCH COMPOUNDS, THEIR USE AND PROCESS FOR THEIR PREPARATION2012-03-01
20120053198WATER-SOLUBLE SOLID PHARMACEUTICAL INCLUSION COMPLEXES AND THEIR AQUEOUS SOLUTIONS FOR ORAL, OPHTHALMIC, TOPICAL OR PARENTERAL USE CONTAINING A MACROLIDE AND CERTAIN CYCLODEXTRINS2012-03-01
20120053199NOSCAPINE AND ANALOGS AND METHODS RELATED THERETO2012-03-01
20120053200BACE 2 INHIBITORS2012-03-01
20120053201SUBSTITUTED HYDROXAMIC ACIDS AND USES THEREOF2012-03-01
20120053202POLYSUBSTITUTED DERIVATIVES OF 6-HETEROARYLIMIDAZO[1,2-a]PYRIDINES, AND PREPARATION AND THERAPEUTIC USE THEREOF2012-03-01
20120053203Substituted 1-oxo-dihydroisoquinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053204Substituted quinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053205Substituted 2-oxy-quinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053206Substituted 2-oxo- and 2-thioxo-dihydroquinoline-3-carboxamides as KCNQ2/3 modulators2012-03-01
20120053207ANTIPSYCHOTIC TREATMENT BASED ON DRD2 OR ANKK1 SNP GENOTYPE2012-03-01
20120053208Curcumin Analogs as Dual JAK2/STAT3 Inhibitors and Methods of Making and Using the Same2012-03-01
20120053209ANTICANCER COMPOUNDS, PREPARATION THEREOF, AND THERAPEUTIC USE THEREOF2012-03-01
20120053210COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM2012-03-01
20120053211TREATMENT OF PANCREATIC CANCER2012-03-01
20120053212METHODS OF TREATING HUMANS UNDERGOING INJECTION OF A CONTRAST AGENT2012-03-01
201200532132-(4-SUBSTITUTED PHENYLAMINO) POLYSUBSTITUTED PYRIDINE COMPOUNDS AS INHIBITORS OF NON-NUCLEOSIDE HIV REVERSE TRANSCRIPTASE, PREPARATION METHODS AND USES THEREOF2012-03-01
20120053214THE LITTLE MOLECULE COMPOUND WHICH USED FOR PROMOTING THE STEM CELLS HYPERPLASIA AND THE USE THEREOF2012-03-01
20120053215ISOTHIAZOLONE-CONTAINING PRESERVATIVE WITH IMPROVED EFFECTIVENESS2012-03-01
20120053216PESTICIDAL COMPOSITIONS2012-03-01
20120053217COMPOSITION FOR PREPARING EMULSION OR MICROEMULSION FORMULATIONS2012-03-01
20120053218TRIAZOLE DERIVATIVES AS VASOPRESSIN-RECEPTOR INHIBITORS FOR TREATING CARDIAC INSUFFICIENCY2012-03-01
20120053219PROCESSES OF MAKING AND USING PHARMACEUTICAL FORMULATIONS OF ANTINEOPLASTIC AGENTS2012-03-01
20120053220NOVEL LIPOXYGENASE INHIBITORS AS NEUROPROTECTIVE AGENTS2012-03-01
20120053221Polymers for Increasing the Soil Mobility of Low-Solubility Insecticides2012-03-01
20120053222Novel Metabolic Disease Therapy2012-03-01
20120053223COMPOSITIONS AND METHODS FOR TREATING RETROVIRUS INFECTIONS2012-03-01